Esta web utiliza cookies para que podamos ofrecerte la mejor experiencia de usuario posible. La información de las cookies se almacena en tu navegador y realiza funciones tales como reconocerte cuando vuelves a nuestra web o ayudar a nuestro equipo a comprender qué secciones de la web encuentras más interesantes y útiles.
Publicaciones realizadas por los miembros de la Fundación.
Carreño V, Bartolomé J, Castillo I, Quiroga JA. Hepatology. 2009 Jun;49(6):2128-9
Identification of serologically silent occult hepatitis C virus infection by detecting immunoglobulin G antibody to a dominant HCV core peptide epitope
Quiroga JA, Castillo I, Llorente S, Bartolomé J, Barril G, Carreño V. J Hepatol. 2009 Feb;50(2):256-63. Epub 2008 Nov 4.
Occult Hepatitis C Virus Infection among Hemodialysis Patients
Barril G, Castillo I, Arenas MD, Espinosa M, Garcia-Valdecasas J, Garcia-Fernández N, González-Parra E, Alcazar JM, Sánchez C, Diez-Baylón JC, Martinez P, Bartolomé J, Carreño V. J Am Soc Nephrol 2008 Dec;19(12):2288-92 Epub 2008 Aug 6
Does occult hepatitis C virus infection exist?
Carreño V, Bartolomé J, Castillo I, Quiroga JA.J Clin Microbiol. 2008 Oct;46(10):3550; author reply 3550-2. No abstract available.
Detection of hepatitis C virus in thyroid tissue from patients with chronic HCV infection
Bartolomé J, Rodríguez-Iñigo E, Quadros P, Vidal S, Pascual-Miguelañez I, Rodríguez-Montes JA, García-Sancho L, Carreño V. J Med Virol 2008;80:1588-94
Occult hepatitis B virus and hepatitis C virus infections
Carreño V, Bartolomé J, Castillo I, Quiroga JA. Rev Med Virol 2008;18:139-57 Review
Hepatitis C virus does not infect muscle, the intervertebral disk, or the meniscus in patients with chronic hepatitis C
Bartolomé J, Rodríguez-Iñigo E, Erice A, Vidal S, Castillo I, Carreño V. J Med Virol 2007;79:1818-20
Serum immunoglobulin G antibodies to the GOR autoepitope are present in patients with occult hepatitis C virus (HCV) infection despite lack of HCV-specific antibodies
Quiroga JA, Castillo I, Bartolomé J, Carreño V. Clin Vaccine Immunol 2007;14:1302-6Virol 2006 (in press)
Current therapy of chronic hepatitis B
Pardo M, Bartolomé J, Carreño V. Arch Med Res 2007;38:661-77 Review
Serum levels of anti-NS4a and anti-NS5a predict treatment response of patients with chronic hepatitis C
Desombere I, Van Vlierberghe H, Weiland O, Hultgren C, Sällberg M, Quiroga J, Carreño V, Leroux-Roels G. J Med Virol 2007;79:701-13
Ultracentrifugation of serum samples allows detection of hepatitis C virus RNA in patients with occult hepatitis C
Bartolomé J, López-Alcorocho JM, Castillo I, Rodríguez-Iñigo E, Quiroga JA, Palacios R, Carreño V. J Virol 2007;81:7710-5
Comparative study between occult hepatitis C virus infection and chronic hepatitis C
Pardo M, López-Alcorocho JM, Rodríguez-Iñigo E, Castillo I, Carreño V. J Viral Hepat 2007;14:36-40
Comparative study on the clinical and virological characteristics among patients with single occult hepatitis B virus (HBV), single occult hepatitis C virus (HCV) and occult HBV and HCV dual infection
Castillo I, Rodríguez-Iñigo E, López-Alcorocho JM, Bartolomé J, Pardo M, Carreño V. J Med Virol 2007;79:236-41
The role of genomic and antigenomic HCV-RNA strands as predictive factors of response to pegylated interferon plus ribavirin therapy
López-Alcorocho JM, Rodríguez-Iñigo E, Castillo I, Castellanos ME, Pardo M, Bartolomé J, Quiroga JA, Carreño V. Aliment Pharmacol Ther 2007;25:1193-201
Occult hepatitis C virus infection: a new form of hepatitis C
Carreño V. World J Gastroenterol 2006;12:6922-5
Cellular immune responses associated with occult hepatitis C virus infection of the liver
Quiroga JA, Llorente S, Castillo I, Rodríguez-Iñigo E, Pardo M, Carreño V. J Virol 2006;80:10972-9
Combined hepatitis C virus (HCV) antigen-antibody detection assay does not improve diagnosis for seronegative individuals with occult HCV infection
Quiroga JA, Castillo I, Pardo M, Rodríguez-Iñigo E, Carreño V. J Clin Microbiol 2006;44:4559-60
Hepatitis C virus replicates in the liver of patients who have a sustained response to antiviral treatment
Castillo I, Rodríguez-Iñigo E, López-Alcorocho JM, Pardo M, Bartolomé J, Carreño V Clin Infect Dis 2006;43:1277-83
Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection
Quiroga JA, Llorente S, Castillo I, Rodríguez-Iñigo E, López-Alcorocho JM, Pardo M, Carreño V. J Med Virol 2006;78:1190-7
Structural characterization of the 5′ untranslated RNA of hepatitis C virus by vibrational spectroscopy
Rodríguez-Casado A, Bartolomé J, Carreño V, Molina M, Carmona P. Biophys Chem 2006;124:73-9